Abstract
Neuronal nicotinic acetylcholine receptors (nAChRs) are critical signaling molecules in a broad variety of fundamental biological processes. In order for cholinergic signaling to function normally, the receptors must be expressed in the appropriate cells at the appropriate times. Expression of the receptors is regulated at many levels from transcription of the receptor subunit genes to posttranslational modifications of individual subunits. Regulating nAChR expression is further complicated because of the large number of genes encoding nAChR subunits, most of which, but not all, are located on distinct chromosomes. Here, we describe molecular events that underlie expression of nAChR subunit genes. We begin with a survey of the transcriptional mechanisms involved in nAChR subunit gene expression including a review of CHRNA5/A3/B4 cluster expression. An update on two emerging fields of investigation, microRNA and epigenetic regulation of nAChR expression, is provided followed by an overview of mechanisms involved in the nicotine-mediated upregulation of nAChR expression. Regulation of nAChR subunit expression is of fundamental importance as it underlies subunit availability, which impacts individual receptor subtype composition and thus, the biophysical properties of the nAChRs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Albuquerque EX, et al. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev. 2009;89(1):73–120.
Woolf NJ, Butcher LL. Cholinergic systems mediate action from movement to higher consciousness. Behav Brain Res. 2011;221(2):488–98.
Simon-Keller K, et al. Targeting the fetal acetylcholine receptor in rhabdomyosarcoma. Expert Opin Ther Targets. 2013;17(2):127–38.
de Almeida JP, Saldanha C. Nonneuronal cholinergic system in human erythrocytes: biological role and clinical relevance. J Membr Biol. 2010;234(3):227–34.
Wallace TL, Bertrand D. Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia. Expert Opin Ther Targets. 2013;17(2):139–55.
Hurst R, Rollema H, Bertrand D. Nicotinic acetylcholine receptors: from basic science to therapeutics. Pharmacol Ther. 2013;137(1):22–54.
Buckingham SD, et al. Nicotinic acetylcholine receptor signalling: roles in Alzheimer’s disease and amyloid neuroprotection. Pharmacol Rev. 2009;61(1):39–61.
Improgo MR, Tapper AR, Gardner PD. Nicotinic acetylcholine receptor-mediated mechanisms in lung cancer. Biochem Pharmacol. 2011;82(8):1015–21.
Steinlein OK. Animal models for autosomal dominant frontal lobe epilepsy: on the origin of seizures. Expert Rev Neurother. 2010;10(12):1859–67.
Le Novere N, Corringer PJ, Changeux JP. The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences. J Neurobiol. 2002;53(4):447–56.
Corringer PJ, Le Novere N, Changeux JP. Nicotinic receptors at the amino acid level. Annu Rev Pharmacol Toxicol. 2000;40:431–58.
Eisele JL, et al. Chimaeric nicotinic-serotonergic receptor combines distinct ligand binding and channel specificities. Nature. 1993;366(6454):479–83.
McGehee DS, Role LW. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol. 1995;57:521–46.
Wang JC, et al. Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence. Mol Psychiatry. 2009;14(5):501–10.
Saccone NL, et al. Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes. Am J Med Genet B Neuropsychiatr Genet. 2009;150B(4):453–66.
Rozycka A, et al. A transcript coding for a partially duplicated form of alpha7 nicotinic acetylcholine receptor is absent from the CD4+ T-lymphocytes of patients with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE). Folia Neuropathol. 2013;51(1):65–75.
Perl O, et al. The alpha7 nicotinic acetylcholine receptor in schizophrenia: decreased mRNA levels in peripheral blood lymphocytes. FASEB J. 2003;17(13):1948–50.
Falvella FS, et al. Transcription deregulation at the 15q25 locus in association with lung adenocarcinoma risk. Clin Cancer Res. 2009;15(5):1837–42.
Gaimarri A, et al. Regulation of neuronal nicotinic receptor traffic and expression. Brain Res Rev. 2007;55(1):134–43.
Son JH, Winzer-Serhan UH. Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs in rat hippocampal GABAergic interneurons. J Comp Neurol. 2008;511(2):286–99.
Son JH, Winzer-Serhan UH. Postnatal expression of alpha2 nicotinic acetylcholine receptor subunit mRNA in developing cortex and hippocampus. J Chem Neuroanat. 2006;32(2–4):179–90.
Ishii K, Wong JK, Sumikawa K. Comparison of alpha2 nicotinic acetylcholine receptor subunit mRNA expression in the central nervous system of rats and mice. J Comp Neurol. 2005;493(2):241–60.
Azam L, et al. Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons. J Comp Neurol. 2002;444(3):260–74.
Keiger CJ, Walker JC. Individual variation in the expression profiles of nicotinic receptors in the olfactory bulb and trigeminal ganglion and identification of alpha2, alpha6, alpha9, and beta3 transcripts. Biochem Pharmacol. 2000;59(3):233–40.
Milton NG, et al. Differential regulation of neuronal nicotinic acetylcholine receptor subunit gene promoters by Brn-3 POU family transcription factors. Biochem J. 1996;317(Pt 2):419–23.
Greenbaum L, Lerer B. Differential contribution of genetic variation in multiple brain nicotinic cholinergic receptors to nicotine dependence: recent progress and emerging open questions. Mol Psychiatry. 2009;14:912–45.
Gotti C, Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol. 2004;74(6):363–96.
Rust G, et al. Expression of neuronal nicotinic acetylcholine receptor subunit genes in the rat autonomic nervous system. Eur J Neurosci. 1994;6(3):478–85.
Zoli M, et al. Developmental regulation of nicotinic ACh receptor subunit mRNAs in the rat central and peripheral nervous systems. J Neurosci. 1995;15(3 Pt 1):1912–39.
Wada E, et al. Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J Comp Neurol. 1989;284(2):314–35.
Flores CM, et al. Neuronal nicotinic rceptor expression in sensory neurons of the rat trigeminal ganglion: demonstration of α3/β4, a novel subtype in the mammalian nervous system. J Neurosci. 1996;16:7892–901.
Liu L, et al. Neuronal nicotinic acetylcholine receptors in rat trigeminal ganglia. Brain Res. 1998;809(2):238–45.
Keiger CJ, et al. Developmental expression of nicotinic receptors in the chick and human spinal cord. J Comp Neurol. 2003;455(1):86–99.
Hellstrom-Lindahl E, et al. Regional distribution of nicotinic receptors during prenatal development of human brain and spinal cord. Brain Res Dev Brain Res. 1998;108(1–2):147–60.
Gahring LC, et al. Mouse strain-specific nicotinic acetylcholine receptor expression by inhibitory interneurons and astrocytes in the dorsal hippocampus. J Comp Neurol. 2004;468(3):334–46.
Winzer-Serhan UH, Leslie FM. Codistribution of nicotinic acetylcholine receptor subunit alpha3 and beta4 mRNAs during rat brain development. J Comp Neurol. 1997;386(4):540–54.
Rogers SW, et al. Neuronal nicotinic acetylcholine receptor expression by O2A/oligodendrocyte progenitor cells. Glia. 2001;33(4):306–13.
Benhammou K, et al. [(3)H]Nicotine binding in peripheral blood cells of smokers is correlated with the number of cigarettes smoked per day. Neuropharmacology. 2000;39(13):2818–29.
Flora A, et al. Neuronal and extraneuronal expression and regulation of the human alpha5 nicotinic receptor subunit gene. J Neurochem. 2000;75(1):18–27.
Glushakov AV, et al. Distribution of neuronal nicotinic acetylcholine receptors containing different alpha-subunits in the submucosal plexus of the guinea-pig. Auton Neurosci. 2004;110(1):19–26.
Macklin KD, et al. Human vascular endothelial cells express functional nicotinic acetylcholine receptors. J Pharmacol Exp Ther. 1998;287(1):435–9.
Wang Y, et al. Human bronchial epithelial and endothelial cells express alpha7 nicotinic acetylcholine receptors. Mol Pharmacol. 2001;60(6):1201–9.
Maus AD, et al. Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors. Mol Pharmacol. 1998;54(5):779–88.
Improgo MR, et al. From smoking to lung cancer: the CHRNA5/A3/B4 connection. Oncogene. 2010;29(35):4874–84.
Benfante R, et al. Transcription factor PHOX2A regulates the human α3 nicotinic receptor subunit gene promoter. J Biol Chem. 2007;282(18):13290–302.
Shimakura J, et al. The transcription factor Cdx2 regulates the intestine-specific expression of human peptide transporter 1 through functional interaction with Sp1. Biochem Pharmacol. 2006;71(11):1581–8.
Yang X, et al. Characterization of an acetylcholine receptor alpha 3 gene promoter and its activation by the POU domain factor SCIP/Tst-1. J Biol Chem. 1994;269(14):10252–64.
Fyodorov D, Deneris E. The POU domain of SCIP/Tst-1/Oct-6 is sufficient for activation of an acetylcholine receptor promoter. Mol Cell Biol. 1996;16(9):5004–14.
McDonough J, Deneris E. Beta43′: an enhancer displaying neural-restricted activity is located in the 3′-untranslated exon of the rat nicotinic acetylcholine receptor beta4 gene. J Neurosci. 1997;17(7):2273–83.
McDonough J, et al. Regulation of transcription in the neuronal nicotinic receptor subunit gene cluster by a neuron-selective enhancer and ETS domain factors. J Biol Chem. 2000;275(37):28962–70.
Fyodorov D, Nelson T, Deneris E. Pet-1, a novel ETS domain factor that can activate neuronal nAchR gene transcription. J Neurobiol. 1998;34(2):151–63.
Yang X, et al. Elements between the protein-coding regions of the adjacent beta 4 and alpha 3 acetylcholine receptor genes direct neuron-specific expression in the central nervous system. J Neurobiol. 1997;32(3):311–24.
Fuentes Medel YF, Gardner PD. Transcriptional repression by a conserved intronic sequence in the nicotinic receptor alpha3 subunit gene. J Biol Chem. 2007;282(26):19062–70.
Improgo MR, et al. ASCL1 regulates the expression of the CHRNA5/A3/B4 lung cancer susceptibility locus. Mol Cancer Res. 2010;8(2):194–203.
Changeux J, Edelstein SJ. Allosteric mechanisms in normal and pathological nicotinic acetylcholine receptors. Curr Opin Neurobiol. 2001;11(3):369–77.
Watanabe H, Zoli M, Changeux JP. Promoter analysis of the neuronal nicotinic acetylcholine receptor alpha4 gene: methylation and expression of the transgene. Eur J Neurosci. 1998;10(7):2244–53.
Eggert M, et al. Nicotinic acetylcholine receptor subunits alpha4 and alpha5 associated with smoking behaviour and lung cancer are regulated by upstream open reading frames. PLoS One. 2013;8(7):e66157.
Wada E, et al. The distribution of mRNA encoded by a new member of the neuronal nicotinic acetylcholine receptor gene family (alpha 5) in the rat central nervous system. Brain Res. 1990;526(1):45–53.
Boulter J, et al. Alpha 3, alpha 5, and beta 4: three members of the rat neuronal nicotinic acetylcholine receptor-related gene family form a gene cluster. J Biol Chem. 1990;265(8):4472–82.
Conroy WG, Vernallis AB, Berg DK. The alpha 5 gene product assembles with multiple acetylcholine receptor subunits to form distinctive receptor subtypes in brain. Neuron. 1992;9(4):679–91.
Improgo MR, et al. The nicotinic acetylcholine receptor CHRNA5/A3/B4 gene cluster: Dual role in nicotine addiction and lung cancer. Prog Neurobiol. 2010;92:212–26.
Bailey CD, et al. The nicotinic acetylcholine receptor alpha5 subunit plays a key role in attention circuitry and accuracy. J Neurosci. 2010;30(27):9241–52.
Fowler CD, et al. Habenular α5 nicotinic receptor subunit signalling controls nicotine intake. Nature. 2011;471(7340):597–601.
Frahm S, et al. Aversion to nicotine is regulated by the balanced activity of β4 and α5 nicotinic receptor subunits in the medial habenula. Neuron. 2011;70(3):522–35.
Exley R, et al. Striatal α5 nicotinic receptor subunit regulates dopamine transmission in dorsal striatum. J Neurosci. 2012;32(7):2352–6.
Moretti M, et al. Nicotinic acetylcholine receptor subtypes expression during rat retina development and their regulation by visual experience. Mol Pharmacol. 2004;66(1):85–96.
Campos-Caro A, et al. Multiple functional Sp1 domains in the minimal promoter region of the neuronal nicotinic receptor alpha5 subunit gene. J Biol Chem. 1999;274(8):4693–701.
Flora A, et al. Transcriptional regulation of the human alpha5 nicotinic receptor subunit gene in neuronal and non-neuronal tissues. Eur J Pharmacol. 2000;393(1–3):85–95.
Gotti C, et al. Brain neuronal nicotinic receptors as new targets for drug discovery. Curr Pharm Des. 2006;12(4):407–28.
Champtiaux N, et al. Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice. J Neurosci. 2002;22(4):1208–17.
Salminen O, et al. Pharmacology of alpha-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice. Mol Pharmacol. 2007;71(6):1563–71.
Ebihara M, et al. Genomic organization and promoter analysis of the human nicotinic acetylcholine receptor alpha6 subunit (CHNRA6) gene: Alu and other elements direct transcriptional repression. Gene. 2002;298(1):101–8.
Munguba GC, et al. Effects of glaucoma on Chrna6 expression in the retina. Curr Eye Res. 2013;38(1):150–7.
Nagavarapu U, Danthi S, Boyd RT. Characterization of a rat neuronal nicotinic acetylcholine receptor alpha7 promoter. J Biol Chem. 2001;276(20):16749–57.
Carrasco-Serrano C, et al. GC- and E-box motifs as regulatory elements in the proximal promoter region of the neuronal nicotinic receptor alpha7 subunit gene. J Biol Chem. 1998;273(32):20021–8.
Matter JM, et al. On the transcriptional regulation of neuronal nAChR genes. J Physiol Paris. 1998;92(3–4):245–8.
Gault J, et al. Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). Genomics. 1998;52(2):173–85.
Criado M, et al. Differential expression of alpha-bungarotoxin-sensitive neuronal nicotinic receptors in adrenergic chromaffin cells: a role for transcription factor Egr-1. J Neurosci. 1997;17(17):6554–64.
Reynolds PR, Hoidal JR. Temporal-spatial expression and transcriptional regulation of alpha7 nicotinic acetylcholine receptor by thyroid transcription factor-1 and early growth response factor-1 during murine lung development. J Biol Chem. 2005;280(37):32548–54.
De Koninck P, Cooper E. Differential regulation of neuronal nicotinic ACh receptor subunit genes in cultured neonatal rat sympathetic neurons: specific induction of alpha 7 by membrane depolarization through a Ca2+/calmodulin-dependent kinase pathway. J Neurosci. 1995;15(12):7966–78.
Zhou X, et al. Brain-derived neurotrophic factor and trkB signaling in parasympathetic neurons: relevance to regulating alpha7-containing nicotinic receptors and synaptic function. J Neurosci. 2004;24(18):4340–50.
Yang X, et al. A cysteine-rich isoform of neuregulin controls the level of expression of neuronal nicotinic receptor channels during synaptogenesis. Neuron. 1998;20(2):255–70.
Aztiria E, Gotti C, Domenici L. Alpha7 but not alpha4 AChR subunit expression is regulated by light in developing primary visual cortex. J Comp Neurol. 2004;480(4):378–91.
Mexal S, et al. Differential regulation of alpha7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers. J Mol Neurosci. 2010;40(1–2):185–95.
Schoepfer R, et al. Brain alpha-bungarotoxin binding protein cDNAs and MAbs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily. Neuron. 1990;5(1):35–48.
Simmons DD, Morley BJ. Spatial and temporal expression patterns of nicotinic acetylcholine α9 and α10 subunits in the embryonic and early postnatal inner ear. Neuroscience. 2011;194:326–36.
Lustig LR. Nicotinic acetylcholine receptor structure and function in the efferent auditory system. Anat Rec A Discov Mol Cell Evol Biol. 2006;288(4):424–34.
Vetter DE, et al. The alpha10 nicotinic acetylcholine receptor subunit is required for normal synaptic function and integrity of the olivocochlear system. Proc Natl Acad Sci U S A. 2007;104(51):20594–9.
Plazas PV, et al. Stoichiometry of the alpha9alpha10 nicotinic cholinergic receptor. J Neurosci. 2005;25(47):10905–12.
Lips KS, Pfeil U, Kummer W. Coexpression of alpha 9 and alpha 10 nicotinic acetylcholine receptors in rat dorsal root ganglion neurons. Neuroscience. 2002;115(1):1–5.
Lustig LR, et al. Molecular cloning and mapping of the human nicotinic acetylcholine receptor alpha10 (CHRNA10). Genomics. 2001;73(3):272–83.
Valor LM, et al. Transcriptional regulation by activation and repression elements located at the 5'-noncoding region of the human alpha9 nicotinic receptor subunit gene. J Biol Chem. 2003;278(39):37249–55.
Picciotto MR, et al. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature. 1998;391(6663):173–7.
Dawson A, Miles MF, Damaj MI. The β2 nicotinic acetylcholine receptor subunit differentially influences ethanol behavioral effects in the mouse. Alcohol. 2013;47(2):85–94.
De Fusco M, et al. The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet. 2000;26(3):275–6.
Bessis A, et al. Promoter elements conferring neuron-specific expression of the β2-subunit of the neuronal nicotinic acetylcholine receptor studied in vitro and in transgenic mice. Neuroscience. 1995;69(3):807–19.
Lueders KK, et al. Genomic organization and mapping of the human and mouse neuronal beta2-nicotinic acetylcholine receptor genes. Mamm Genome. 1999;10(9):900–5.
Bessis A, et al. The neuron-restrictive silencer element: a dual enhancer/silencer crucial for patterned expression of a nicotinic receptor gene in the brain. Proc Natl Acad Sci U S A. 1997;94:5906–11.
Hoft NR, et al. CHRNB2 promoter region: association with subjective effects to nicotine and gene expression differences. Genes Brain Behav. 2011;10(2):176–85.
Oh SH, Kim CS, Song JJ. Gene expression and plasticity in the rat auditory cortex after bilateral cochlear ablation. Acta Otolaryngol. 2007;127(4):341–50.
Hoft NR, et al. Genetic association of the CHRNA6 and CHRNB3 genes with tobacco dependence in a nationally representative sample. Neuropsychopharmacology. 2009;34(3):698–706.
Mandelzys A, et al. The developmental increase in ACh current densities on rat sympathetic neurons correlates with changes in nicotinic ACh receptor alpha-subunit gene expression and occurs independent of innervation. J Neurosci. 1994;14(4):2357–64.
Dineley-Miller K, Patrick J. Gene transcripts for the nicotinic acetylcholine receptor subunit, beta4, are distributed in multiple areas of the rat central nervous system. Brain Res Mol Brain Res. 1992;16(3–4):339–44.
Di Angelantonio S, et al. Molecular biology and electrophysiology of neuronal nicotinic receptors of rat chromaffin cells. Eur J Neurosci. 2003;17(11):2313–22.
Melnikova IN, Gardner PD. The signal transduction pathway underlying ion channel gene regulation by SP1-C-Jun interactions. J Biol Chem. 2001;276(22):19040–5.
Melnikova IN, et al. Synergistic transcriptional activation by Sox10 and Sp1 family members. Neuropharmacology. 2000;39(13):2615–23.
Melnikova IN, Yang Y, Gardner PD. Interactions between regulatory proteins that bind to the nicotinic receptor beta4 subunit gene promoter. Eur J Pharmacol. 2000;393(1–3):75–83.
Scofield MD, et al. Transcription factor assembly on the nicotinic receptor beta4 subunit gene promoter. Neuroreport. 2008;19(6):687–90.
Du Q, Tomkinson AE, Gardner PD. Transcriptional regulation of neuronal nicotinic acetylcholine receptor genes. A possible role for the DNA-binding protein Puralpha. J Biol Chem. 1997;272(23):14990–5.
Du Q, Melnikova IN, Gardner PD. Differential effects of heterogeneous nuclear ribonucleoprotein K on Sp1- and Sp3-mediated transcriptional activation of a neuronal nicotinic acetylcholine receptor promoter. J Biol Chem. 1998;273(31):19877–83.
Krecic AM, Swanson MS. hnRNP complexes: composition, structure, and function. Curr Opin Cell Biol. 1999;11:363–71.
Da Silva N, Bharti A, Shelley CS. hnRNP-K and Purα act together to repress the transcriptional activity of the CD43 gene promoter. Blood. 2002;100(10):3536–44.
Bruschweiler-Li L, et al. Temporally- and spatially-regulated transcriptional activity of the nicotinic acetylcholine receptor beta4 subunit gene promoter. Neuroscience. 2010;166(3):864–77.
Scofield MD, Tapper AR, Gardner PD. A transcriptional regulatory element critical for CHRNB4 promoter activity in vivo. Neuroscience. 2010;170(4):1056–64.
Fornasari D, et al. Transcriptional regulation of neuronal nicotinic receptor subunit genes. In: Arneric SP, Brioni JD, editors. Neuronal nicotinic receptors: pharmacology and therapeutic opportunities. Wilmington, DE: Wiley-Liss Inc.; 1998.
Fornasari D, et al. Structural and functional characterization of the human alpha3 nicotinic subunit gene promoter. Mol Pharmacol. 1997;51(2):250–61.
Pugh BF, Tjian R. Transcription from a TATA-less promoter requires a multisubunit TFIID complex. Genes Dev. 1991;5:1935–9145.
Liu Q, et al. Cell type-specific activation of neuronal nicotinic acetylcholine receptor subunit genes by Sox10. J Neurosci. 1999;19(22):9747–55.
Corriveau RA, Berg DK. Coexpression of multiple acetylcholine receptor genes in neurons: quantitation of transcripts during development. J Neurosci. 1993;13:2662–71.
Zhou Y, Deneris E, Zigmond RE. Differential regulation of levels of nicotinic receptor subunit transcripts in adult sympathetic neurons after axotomy. J Neurobiol. 1998;34(2):164–78.
Xu X, Scott MM, Deneris ES. Shared long-range regulatory elements coordinate expression of a gene cluster encoding nicotinic receptor heteromeric subtypes. Mol Cell Biol. 2006;26(15):5636–49.
Friedman RC, et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19(1):92–105.
Cao X, et al. Noncoding RNAs in the mammalian central nervous system. Annu Rev Neurosci. 2006;29:77–103.
Bicker S, Schratt G. microRNAs: tiny regulators of synapse function in development and disease. J Cell Mol Med. 2008;12(5A):1466–76.
Fiore R, Siegel G, Schratt G. MicroRNA function in neuronal development, plasticity and disease. Biochim Biophys Acta. 2008;1779(8):471–8.
Ameres SL, Zamore PD. Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol. 2013;14(8):475–88.
Balaraman S, Winzer-Serhan UH, Miranda RC. Opposing actions of ethanol and nicotine on microRNAs are mediated by nicotinic acetylcholine receptors in fetal cerebral cortical-derived neural progenitor cells. Alcohol Clin Exp Res. 2012;36(10):1669–77.
Schembri F, et al. MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc Natl Acad Sci U S A. 2009;107(7):2319–24.
Izzotti A, et al. Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J. 2009;23(3):806–12.
Shan H, et al. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res. 2009;83(3):465–72.
Huang W, Li MD. Nicotine modulates expression of miR-140*, which targets the 3′-untranslated region of dynamin 1 gene (Dnm1). Int J Neuropsychopharmacol. 2009;12(4):537–46.
Lippi G, et al. Targeting of the Arpc3 actin nucleation factor by miR-29a/b regulates dendritic spine morphology. J Cell Biol. 2011;194(6):889–904.
Simon D, et al. The microRNA miR-1 regulates a MEF-2-dependent retrograde signal at neuromuscular junctions. Cell. 2008;2133(5):903–15.
Jablonka E. Epigenetic variations in heredity and evolution. Clin Pharmacol Ther. 2012;92(6):683–8.
Rando OJ, Verstrepen KJ. Timescales of genetic and epigenetic inheritance. Cell. 2007;128(4):655–68.
Van Speybroeck L. From epigenesis to epigenetics: the case of C. H. Waddington. Ann N Y Acad Sci. 2002;981:61–81.
Brower V. Epigenetics: unravelling the cancer code. Nature. 2011;471(7339):S12–3.
Stower H. Epigenetics: dynamic DNA methylation. Nat Rev Genet. 2012;13(2):75.
Canastar A, et al. Promoter methylation and tissue-specific transcription of the alpha7 nicotinic receptor gene, CHRNA7. J Mol Neurosci. 2012;47(2):389–400.
Maloku E, et al. Selective α4β2 nicotinic acetylcholine receptor agonists target epigenetic mechanisms in cortical GABAergic neurons. Neuropsychopharmacology. 2011;36(7):1366–74.
Paliwal A, et al. Aberrant DNA methylation links cancer susceptibility locus 15q25.1 to apoptotic regulation and lung cancer. Cancer Res. 2010;70(7):2779–88.
Scherf DB, et al. Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4. Oncogene. 2012;32:3329–38.
Caporaso N, et al. Genome-wide and candidate gene association study of cigarette smoking behaviors. PLoS One. 2009;4(2):e4653.
Yasui DH, et al. 15q11.2-13.3 chromatin analysis reveals epigenetic regulation of CHRNA7 with deficiencies in Rett and autism brain. Hum Mol Genet. 2011;20(22):4311–23.
Chahrour M, et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science. 2008;320(5880):1224–9.
Bencherif M, et al. Mechanisms of up-regulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain. J Pharmacol Exp Ther. 1995;275(2):987–94.
Govind AP, Vezina P, Green WN. Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction. Biochem Pharmacol. 2009;78(7):756–65.
Fenster CP, et al. Upregulation of surface alpha4beta2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine. J Neurosci. 1999;19(12):4804–14.
Buisson B, Bertrand D. Chronic exposure to nicotine upregulates the human (alpha)4((beta)2 nicotinic acetylcholine receptor function. J Neurosci. 2001;21(6):1819–29.
Marks MJ, et al. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci. 1992;12(7):2765–84.
Huang LZ, Winzer-Serhan UH. Chronic neonatal nicotine upregulates heteromeric nicotinic acetylcholine receptor binding without change in subunit mRNA expression. Brain Res. 2006;1113(1):94–109.
Srinivasan R, et al. Nicotine up-regulates alpha4beta2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning. J Gen Physiol. 2010;137(1):59–79.
Peng X, et al. Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol Pharmacol. 1994;46:523–30.
Darsow T, et al. Exocytic trafficking is required for nicotine-induced up-regulation of alpha 4 beta 2 nicotinic acetylcholine receptors. J Biol Chem. 2005;280(18):18311–20.
Nashmi R, et al. Assembly of α4β2 nicotinic acetylcholine receptors assessed with functional fluorescently labeled subunits: effects of localization, trafficking, and nicotine-induced upregulation in clonal mammalian cells and in cultured midbrain neurons. J Neurosci. 2003;23:11554–67.
Sallette J, et al. Nicotine upregulates its own receptors through enhanced intracellular maturation. Neuron. 2005;46(4):595–607.
Ficklin MB, Zhao S, Feng G. Ubiquilin-1 regulates nicotine-induced up-regulation of neuronal nicotinic acetylcholine receptors. J Biol Chem. 2005;280:34088–95.
Rezvani K, et al. Nicotine regulates multiple synaptic proteins by inhibiting proteosomal activity. J Neurosci. 2007;27:10508–19.
Nelson ME, Kuryatov A, Choi CH, Zhou Y, Lindstrom J. Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors. J Mol Pharmacol. 2003;63(2):332–41.
Moroni M, et al. alpha4beta2 nicotinc receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine. Mol Pharmacol. 2006;70:755–68.
Vallejo Y, et al. Chronic nicotine exposure upregulates nicotinic receptors by a novel mechanism. J Neurosci. 2005;25(23):5563–72.
Walsh H, et al. Up-regulation of nicotinic receptors by nicotine varies with receptor subtype. J Biol Chem. 2008;283(10):6022–32.
Columbo SF, et al. Biogenesis, trafficking and up-regulation of nicotinic ACh recpetors. Biochem Pharmacol. 2013;86:1063–73.
Kuryatov A, et al. Nicotine acts as a pharmacological chaperone to up-regulate human alpha4beta2 acetylcholine receptors. Mol Pharmacol. 2005;68(6):1839–51.
Govind AP, Walsh H, Green WN. Nicotine-induced upregulation of native neuronal nicotinic receptors is caused by multiple mechanisms. J Neurosci. 2012;32(6):2227–38.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Scofield, M.D., Gardner, P.D. (2014). Molecular Underpinnings of Neuronal Nicotinic Acetylcholine Receptor Expression. In: Lester, R. (eds) Nicotinic Receptors. The Receptors, vol 26. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1167-7_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1167-7_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1166-0
Online ISBN: 978-1-4939-1167-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)